Melanoma helper peptide vaccine
Term · Oncology and biomedicine · MLC-T-ONC-015076
A multivalent vaccine consisting of peptides derived from melanoma-associated antigens and an adjuvant peptide derived from tetanus toxoid. Vaccination with this agent may stimulate a host cytotoxic T-cell response against tumor cells expressing melanoma-associated antigens, resulting in tumor cell lysis.
| Identifier | MLC-T-ONC-015076 |
|---|---|
| Field | Oncology and biomedicine |
| Abbreviation | MHP VAC |
| References | National Cancer Institute Thesaurus (CC BY 4.0) |
Record as JSON
{
"id": "MLC-T-ONC-015076",
"term": "Melanoma helper peptide vaccine",
"field": "Oncology and biomedicine",
"definition": "A multivalent vaccine consisting of peptides derived from melanoma-associated antigens and an adjuvant peptide derived from tetanus toxoid. Vaccination with this agent may stimulate a host cytotoxic T-cell response against tumor cells expressing melanoma-associated antigens, resulting in tumor cell lysis.",
"abbreviation": "MHP VAC",
"references": [
"National Cancer Institute Thesaurus"
],
"url": "https://mlchart.com/terminology/oncology/melanoma-helper-peptide-vaccine/"
}
Record 10,796 of 17,717 in Oncology and biomedicine terminology (MLC-0111). Request the full dataset.